Showing 1 - 10 results of 10 for search 'M. Reichert', query time: 0.03s
Refine Results
-
1
Clinical development of therapeutic recombinant proteins by Janice M. Reichert, Cherie Paquette
Published 2003-07-01
Article -
2
-
3
-
4
Antibodies to watch in 2023 by Hélène Kaplon, Silvia Crescioli, Alicia Chenoweth, Jyothsna Visweswaraiah, Janice M. Reichert
Published 2023-12-01
Article -
5
Antibodies to watch in 2024 by Silvia Crescioli, Hélène Kaplon, Alicia Chenoweth, Lin Wang, Jyothsna Visweswaraiah, Janice M. Reichert
Published 2024-12-01
Article -
6
Antibodies to watch in 2025 by Silvia Crescioli, Hélène Kaplon, Lin Wang, Jyothsna Visweswaraiah, Vaishali Kapoor, Janice M. Reichert
Published 2025-12-01
Article -
7
-
8
Reduced preoperative serum choline esterase levels and fecal peritoneal contamination as potential predictors for the leakage of intestinal sutures after source control in secondar... by A. L. Amati, R. Ebert, L. Maier, A. K. Panah, T. Schwandner, M. Sander, M. Reichert, V. Grau, S. Petzoldt, A. Hecker
Published 2024-06-01
Article -
9
Evaluation of a unique and innovative diabetes care model in primary care in Ontario, Canada: protocol for a multiple-methods study with a convergent parallel design by Lindsay Hedden, Maria Mathews, Stewart Harris, Yun-Hee Choi, Jennifer Donnan, Leslie Meredith, Bridget Ryan, Michael E Green, Rhiannon Lyons, Elisabeth Harvey, Sonja M. Reichert, Shannon Sibbald
Published 2024-06-01
Article -
10
TROPHIT1—a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients by B.C. Köhler, G.M. Haag, L. Le Cornet, P. Hoffmeister-Wittmann, M. Schmidt, A. Manjunath, N. Vaquero-Siguero, M. Jenzer, M. Gimmel, A. Stahler, A. Stein, M. Reichert, S. Kasper, M. Bitzer, D. Jäger, C. Springfeld, T.F. Weber, S. Fröhling, K. Steindorf, A. Trumpp, R.F. Schlenk, R. Jackstadt
Published 2025-03-01
Article